Objective: The range of unnoticed physical disorders in patients diagnosed with a psychogenic disorder varies widely. We investigated the accuracy of the clinical diagnosis of ‘psychogenic disorder’ where physical symptoms suggesting a somatic condition (PDPS) are present. Method: All 162 cases of PDPS diagnosed between 01.01.1986 and 31.12.1987 in a medical clinic specializing in psychosomatic medicine were reviewed after 5 years. 148 follow-ups were complete. Initial diagnoses had been established using positive criteria for psychogenic diagnosis in a semistructured interview and a comprehensive clinical workup by trained clinicians. Results: In 2 (1.35%) foreign-language patients of 148 an orthopedic diagnosis had been missed. In 6 patients, the family physician gave formerly known findings a different interpretation. Half of these patients were foreigners; 5 were men; none improved; 5 had back pain. Conclusion: A semistructured interview and positive criteria for psychogenic diagnosis permitted high diagnostic accuracy with an error of 1.35% in 148 cases.

Keywords:
Diagnostic errors, Follow-up, Interview, Pain, Psychogenic disorder
1.
Slater E: Diagnosis of ‘hysteria’. BMJ 1965;i:1395–1399.
2.
Comroe BI: Follow-up study of 100 patients diagnosed as ‘neurosis’. J Nerv Ment Dis 1936;83:679–684.
3.
Carter AB: The prognosis of certain hysterical symptoms. BMJ 1949;i:1076–1079.
4.
Ljungberg L: Hysteria: A clinical, prognostic and genetic study. Acta Psychiatr Neurol Scand Suppl 1957;112.
5.
Gatefield PD, Guze SB: Prognosis and differential diagnosis of conversion reactions: A follow-up study. Dis Nerv Syst 1962;23:623–631.
6.
Slater ETO, Glithero E: A follow-up of patients diagnosed as suffering from ‘hysteria’. J Psychosom Res 1965;9:9–13.
7.
Raskin M, Talbott JA, Meyerson AT: Diagnosis of conversion reactions: Predictive value of psychiatric criteria. JAMA 1966;197:530–534.
8.
Reed JL: The diagnosis of ‘hysteria’. Psychol Med 1975;5:13–17.
9.
Stefánsson JG, Messina JA, Meyerowitz S: Hysterical neurosis, conversion type: Clinical and epidemiological considerations. Acta Psychiatr Scand 1976;53:119–138.
10.
Barraclough D, Russell AS, Percy JS: Diagnosis and follow-up of children referred to a rheumatic disease unit. Med J Aust 1977;i:920–923.
11.
Watson CG, Buranen C: The frequency and identification of false positive conversion reactions. J Nerv Ment Dis 1979;167:243–247.
12.
Krumholz A, Niedermeyer E: Psychogenic seizures: A clinical study with follow-up data. Neurology 1983;33:498–502.
13.
Guze SB, Cloninger CR, Martin RL, Clayton PJ: A follow-up and family study of Briquet’s syndrome. Br J Psychiatry 1986;149:17–23.
14.
Stacher G, Wiesnagrotzki S, Kiss A: Symptoms of achalasia in young women mistaken as indicating primary anorexia nervosa. Dysphagia 1990;5:216–219.
15.
Spierings C, Poels PJ, Sijben N, Gabreels FJ, Renier WO: Conversion disorders in childhood: A retrospective follow-up study of 84 inpatients. Dev Med Child Neurol 1990;32:865–871.
16.
Hendler NH, Kozikowski JG: Overlooked physical diagnoses in chronic pain patients involved in litigation. Psychosomatics 1993;34:494–501.
17.
Kent DA, Tomasson K, Coryell W: Course and outcome of conversion and somatization disorders. Psychosomatics 1995;36:138–144.
18.
Sharma P, Chaturvedi SK: Conversion disorder revisited. Acta Psychiatr Scand 1995;92:301–304.
19.
Crimlisk HL, Bhatia K, Cope H, David A, Marsden CD, Ron MA: Slater revisited: 6 year follow-up study of patients with medically unexplained motor symptoms. BMJ 1998;316:582–586.
20.
Tissenbaum MJ, Harter HM, Friedman AP: Organic neurological syndromes diagnosed as functional disorders. JAMA 1951;147:1519–1521.
21.
Eldridge R, Riklan M, Cooper IS: The limited role of psychotherapy in torsion dystonia. JAMA 1969;210:705–708.
22.
Marsden CD, Harrison MJG: Idiopathic torsion dystonia (dystonia musculorum deformans): A review of forty-two patients. Brain 1974;97:793–810.
23.
Cooper IS, Cullinan T, Riklan M: The natural history of dystonia. Adv Neurol 1976;14:157–169.
24.
Lesser RP, Fahn S: Dystonia: A disorder often misdiagnosed as a conversion reaction. Am J Psychiatry 1978;135:349–352.
25.
Admans H, Whorwell PJ, Wright R: Diagnosis of Crohn’s disease. Dig Dis Sci 1980;25:911–915.
26.
Sneddon J: Myasthenia gravis: The difficult diagnosis. Br J Psychiatry 1980;136:92–93.
27.
Nicholson GA, Wilby J, Tennant C: Myasthenia gravis: The problem of a ‘psychiatric’ misdiagnosis. Med J Aust 1986;144:632–638.
28.
Rohr W: Myasthenia gravis im Grenzgebiet psychiatrischer Diagnostik. Psychiatr Prax 1992;19:157–163.
29.
Skegg K, Corwin PA, Skegg DCG: How often is multiple sclerosis mistaken for a psychiatric disorder? Psychol Med 1988;18:733–736.
30.
Dahl RE, Holttum J, Trubnick L: A clinical picture of child and adolescent narcolepsy. J Am Acad Child Adolesc Psychiatry 1994;33:834–841.
31.
Walters AS, Hickey K, Maltzman J, Verrico T, Joseph D, Hening W, Wilson V, Chokroverty S: A questionnaire study of 138 patients with restless legs syndrome: The ‘night-walkers’ survey. Neurology 1996;46:92–95.
32.
Henningsen P, Clement U, Küchenhoff J, Simon F, Meinck HM: Psychological factors in the diagnosis and pathogenesis of stiff-man syndrome. Neurology 1996;47:38–42.
33.
Engel GL: Conversion symptoms; in Blacklow RS (ed): Mac Bryde’s Signs and Symptoms, ed 6. Philadelphia, Lippincott, 1983, pp 623–646.
34.
Engel GL, Schmale AH: Conservation-withdrawal: A primary regulatory process for organismic homeostasis; in Porter R, Knight J (eds): Physiology, emotion and psychosomatic illness. Ciba Found Symp 8 (new series), Ciba Found, London, April 1972. Amsterdam, Elsevier Excerpta Medica/North-Holland, 1972, pp 57–85.
35.
Engel GL: Psychological Development in Health and Disease. Philadelphia, Saunders, 1962.
36.
Drossman DA: Patients with psychogenic abdominal pain: Six years’ observation in the medical setting. Am J Psychiatry 1982;139:1549–1557.
37.
Sauvant JD, Hürny C, Adler RH, Hemmeler W: Validität der Diagnose ‘psychogener Schmerz’ bei der Kontrolle nach fünf Jahren. Schweiz Rundsch Med Prax 1988;77:1379–1382.
38.
Groeneweg CE, Sidler D, Vasella DL, Adler RH: Das Verpassen somatischer Krankheiten: Berechtigte Furcht oder Chimäre? Schweiz Rundsch Med Prax 1991;80:529–536.
39.
Porcelli P, De Carne M, Fava GA: Assessing somatization in functional gastrointestinal disorders: Integration of different criteria. Psychother Psychosom 2000;69:198–204.
40.
Schneider G, Kruse A, Nehen HG, Senf W, Heuft G: The prevalence and differential diagnosis of subclinical depressive syndromes in inpatients 60 years and older. Psychother Psychosom 2000;69:251–260.
41.
Strasser H: Psychosomatik und Rehabilitation. Rehabilitation 1982;21:21–28.
42.
Engel GL: The need for a new medical model: A challenge for biomedicine. Science 1977;196:129–136.
43.
Engel GL: How much longer must medicine’s science be bound by a seventeenth century world view? Psychother Psychosom 1992;57:3–16.
44.
von Uexküll T, Wesiack W. Wissenschaftstheorie: Ein bio-psycho-soziales Modell; in von Uexküll T (Hrsg): Psychosomatische Medizin, neubearbeitete und erweiterte Aufl 5. München, Urban & Schwarzenberg, 1996, Kapitel 1.
45.
von Uexküll T, Wesiack W: Theorie der Humanmedizin: Grundlagen ärztlichen Denkens und Handelns, Aufl 2. München, Urban & Schwarzenberg, 1991.
46.
Morgan WL Jr, Engel GL: The Clinical Approach to the Patient. Philadelphia, Saunders, 1969.
47.
Adler RH, Hemmeler W: Anamnese und Körperuntersuchung: Der biologische, psychische und soziale Zugang zum Patienten, überarbeitete und erweiterte Aufl 3. Stuttgart, Fischer, 1992.
48.
Adler RH: Schmerz; in von Uexküll T (ed): Psychosomatische Medizin, neubearbeitete und erweiterte Aufl 5. München, Urban & Schwarzenberg, 1996.
49.
Adler RH: The differentiation of organic and psychogenic pain. Pain 1981;10:249–252.
50.
Radvila A, Adler RH, Hürny C: Interview-derived variables and countertransference reactions in the differentiation of psychogenic versus organic pain. Psychosom Med 1989;51:263.
51.
Kaplan C: Hypothesis testing; in Lipkin M, Putnam SM, Lazare A (eds): The Medical Interview: Clinical Care, Education and Research. New York, Springer, 1994, pp 20–31.
52.
Deathe AB, Helmes E: Evaluation of a chronic pain programme by referring physicians. Pain 1993;52:113–121.
53.
Sells SP, Smith TE, Sprenkle DH: Integrating qualitative and quantitative research methods: A research model. Fam Process 1995;34:199–218.
54.
Brähler E, Adler C: Quantitative Einzelfallanalysen und qualitative Verfahren. Giessen, Psychosozial-Verlag, 1996.
55.
Mayring P: Einführung in die qualitative Sozialforschung: Eine Anleitung zu qualitativem Denken, Aufl 2. München, Psychologie Verlags Union, 1993.
56.
Dean AG, Dean JA, Coulombier D, et al: EPI Info, Version 6: A Word Processing, Database, and Statistics Program for Epidemiology and Microcomputers. Atlanta, Centres for Disease Control and Prevention, 1994.
57.
Schulberg HC, Burns BJ: Mental disorders in primary care: Epidemiologic, diagnostic, and treatment research directions. Gen Hosp Psychiatry 1988;10:79–87.
58.
Barrett JE, Barrett JA, Oxman TE, Gerber PD: The prevalence of psychiatric disorders in a primary care practice. Arch Gen Psychiatry 1988;45:1100–1106.
59.
Spitzer RL, Williams JBW, Kroenke K, Linzer M, deGruy FV, Hahn SR, Brody D, Johnson JG: Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 study. JAMA 1994;272:1749–1756.
60.
Jensen MC, Brant-Zawadzki MN, Obuchowski N, Modic MT, Malkasian D, Ross JS: Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med 1994;331:69–73.
61.
Cannon WB: Bodily changes in pain, hunger, fear and rage: An account of recent researches into the function of emotional excitement, ed 2. New York, Appleton, 1929.
62.
Hoffmann SO, Egle UT: Der Schmerzkranke: Grundlagen, Pathogenese, Klinik und Therapie chronischer Schmerzsyndrome aus bio-psycho-sozialer Sicht. Stuttgart, Schattauer, 1993, p 95.
63.
Blazer DG: Narcissism and the development of chronic pain. Int J Psychiatry Med 1980/1981;10:69–77.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.